GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cosmos Health Inc (NAS:COSM) » Definitions » Net Income Including Noncontrolling Interests

COSM (Cosmos Health) Net Income Including Noncontrolling Interests : $-15.14 Mil (TTM As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Cosmos Health Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Cosmos Health's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2025 was $-0.82 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 was $-15.14 Mil.


Cosmos Health Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Cosmos Health's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmos Health Net Income Including Noncontrolling Interests Chart

Cosmos Health Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 -7.96 -13.83 -18.54 -16.18

Cosmos Health Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.87 -2.59 -2.18 -9.54 -0.82

Cosmos Health Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-15.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cosmos Health Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Cosmos Health's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Cosmos Health Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cosmos Health Inc (NAS:COSM) » Definitions » Net Income Including Noncontrolling Interests
Traded in Other Exchanges
N/A
Address
5 Agiou Georgiou Street, Thessaloniki, Thessaloniki, GRC, 55438
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Executives
Grigorios Siokas 10 percent owner 5 AG. GEORGIOU STR., PILEA, THESSALONIKI J3 TK57001
Georgios Terzis officer: Chief Financial Officer 2 MELITOS STR., NEA SMIRNI, ATTICA J3 17121
Suhel Bhutawala director 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Nikolaos Bardakis officer: Chief Operating Officer 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Manfred Ziegler director 141 WEST JACKSON BOULEVARD, SUITE 4236, CHICAGO IL 60604
Anastasios Aslidis director 11 CANTERBURY LANE, WATCHUNG NJ 07069
Pavlos Ignatiades officer: Chief Operating Officer KALAPATHAKI 5, PANORAMA, THESSALONIKI J3 55236
Peter Goldstein director 151 NORTH NOB HILL ROAD SUITE 321, FORT LAUDERDALE FL 33324
John James Hoidas director 9301 S. HARLEM AVENUE, OAK LAWN, CHICAGO IL 60453
Dimitrios Goulielmos director, 10 percent owner, officer: CEO 141 WEST JACKSON BLVD, SUITE 4236, CHICAGO IL 60604
Panagiotis Tolis director, officer: Secretary PERICLEOUS 50 STREET, ATHENS J3 15232
Panagiotis Drakopoulos director, 10 percent owner, officer: CEO 200 SOUTH WACKER DRIVE, SUITE 300, CHICAGO IL 60606
Vasileios Mavrogiannis director, 10 percent owner, officer: CFO TERTSETI 23 STREET, KESARIANI J3 16122

Cosmos Health Headlines

From GuruFocus